Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ENSC similar filings
- 17 Aug 21 Ensysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
- 21 Jul 21 Regulation FD Disclosure
- 8 Jul 21 Company’s Proprietary TAAP Prodrug Delivery and Overdose Technology Aims to Stem The Opioid Abuse Epidemic
- 7 Jul 21 Entry into a Material Definitive Agreement
- 1 Jul 21 Regulation FD Disclosure
- 1 Jul 21 Ensysce Biosciences Announces Closing of Merger
- 30 Jun 21 Submission of Matters to a Vote of Security Holders
Filing view
External links
Exhibit 16.1
July 7, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
We have read the statements made by Ensysce Biosciences, Inc. (formerly known as Leisure Acquisition Corp.) under Item 4.01 of its Form 8-K dated July 7, 2021. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Ensysce Biosciences, Inc. contained therein.
Very truly yours, | |
Marcum LLP | |